Novavax Inc (NVAX)

[mick]

NVAX A future leader
So, now you might be thinking potential for share gains is a thing of the past. Not necessarily. Three important elements could make Novavax an eventual leader in the coronavirus vaccine field -- and result in stock market performance along the way.

I'll talk about two of these elements at the same time, as they both have to do with logistics. They are storage and capacity. Novavax's vaccine can be stored between 35 degrees and 46 degrees Fahrenheit. Those are standard refrigerator temperatures. That means the potential product doesn't require the expense or logistical headaches of investing in special equipment to transport and store it. This gives Novavax an edge over Pfizer. The big pharma's vaccine candidate must be maintained at negative 94 degrees Fahrenheit.